Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 481 AL 495

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure

Ogonowski NS, García-Marín LM, Fernando AS, Flores-Ocampo V, Rentería ME.

Transl Psychiatry. 2024 Apr 11;14(1):185. doi: 10.1038/s41398-024-02898-9.

Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review

Kovalová M, Gottfriedová N, Mrázková E, Janout V, Janoutová J.

Otolaryngol Pol. 2024 Apr 9;78(2):1-17. doi: 10.5604/01.3001.0053.6158.

Inorganic polyphosphate: from basic research to diagnostic and therapeutic opportunities in ALS/FTD

Garcés P, Amaro A, Montecino M, van Zundert B.

Biochem Soc Trans. 2024 Feb 28;52(1):123-135. doi: 10.1042/BST20230257.

Regulatory mechanism of circular RNAs in neurodegenerative diseases

Xiao F, He Z, Wang S, Li J, Fan X, Yan T, Yang M, Yang D.

CNS Neurosci Ther. 2024 Apr;30(4):e14499. doi: 10.1111/cns.14499. Epub 2023 Oct 21.

A closer look at amyloid ligands, and what they tell us about protein aggregates

Chisholm TS, Hunter CA.

Chem Soc Rev. 2024 Feb 5;53(3):1354-1374. doi: 10.1039/d3cs00518f.

[Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics]

Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F.

Nervenarzt. 2024 Apr;95(4):353-361. doi: 10.1007/s00115-023-01576-3. Epub 2023 Dec 13.

In Vivo Assays for Amyloid-Related Diseases

Espargaró A, Álvarez-Berbel I, Busquets MA, Sabate R.

Annu Rev Anal Chem (Palo Alto Calif). 2024 Jul;17(1):433-458. doi: 10.1146/annurev-anchem-061622-023326. Epub 2024 Jul 2.

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Chudzik A, Śledzianowski A, Przybyszewski AW.

Sensors (Basel). 2024 Feb 29;24(5):1572. doi: 10.3390/s24051572.

Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers

Bisi N, Pinzi L, Rastelli G, Tonali N.

Molecules. 2024 Feb 4;29(3):722. doi: 10.3390/molecules29030722.

Designing and Formulation of Nanocarriers for "Alzheimer's and Parkinson's" Early Detection and Therapy

Abujamai J, Satar R, Ansari SA.

CNS Neurol Disord Drug Targets. 2024;23(10):1251-1262. doi: 10.2174/0118715273297024240201055550.

Prevalence, treatment, and neural correlates of apathy in different forms of dementia: a narrative review

Parrotta I, Cacciatore S, D'Andrea F, D'Anna M, Giancaterino G, Lazzaro G, Arcara G, Manzo N.

Neurol Sci. 2024 Apr;45(4):1343-1376. doi: 10.1007/s10072-023-07197-7. Epub 2023 Nov 28.

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

Casciano F, Zauli E, Celeghini C, Caruso L, Gonelli A, Zauli G, Pignatelli A.

Int J Mol Sci. 2024 Jan 30;25(3):1689. doi: 10.3390/ijms25031689.

Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases

Sarkar S, Roy D, Chatterjee B, Ghosh R.

Metabolomics. 2024 Mar 8;20(2):37. doi: 10.1007/s11306-024-02100-7.

The Olfactory Trail of Neurodegenerative Diseases

Franco R, Garrigós C, Lillo J.

Cells. 2024 Apr 2;13(7):615. doi: 10.3390/cells13070615.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias